These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7361796)

  • 1. Phenytoin toxicity and blood levels after a large oral dose.
    Evens RP; Fraser DG; Ludden TM; Sutherland EW
    Am J Hosp Pharm; 1980 Feb; 37(2):232-5. PubMed ID: 7361796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption characteristics of three phenytoin sodium products after administration of oral loading doses.
    Goff DA; Spunt AL; Jung D; Bellur SN; Fischer JH
    Clin Pharm; 1984; 3(6):634-8. PubMed ID: 6509876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral phenytoin loading in adults: rapid achievement of therapeutic plasma levels.
    Record KE; Rapp RP; Young AB; Kostenbauder HB
    Ann Neurol; 1979 Mar; 5(3):268-70. PubMed ID: 443759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid infusion of phenytoin sodium loading doses.
    Salem RB; Wilder BJ; Yost RL; Doering PL; Lee C
    Am J Hosp Pharm; 1981 Mar; 38(3):354-7. PubMed ID: 7223748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of phenytoin sodium capsules available in Thailand. Part II: In vivo study.
    Suthisisang C; Payakachat N; Chulavatnatol S; Towanabut S
    J Med Assoc Thai; 1998 Jan; 81(1):64-70. PubMed ID: 9470324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenytoin pharmacokinetics in burned rats and plasma protein binding of phenytoin in burned patients.
    Bowdle TA; Neal GD; Levy RH; Heimbach DM
    J Pharmacol Exp Ther; 1980 Apr; 213(1):97-9. PubMed ID: 7359372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral loading dose of phenytoin in the treatment of serial seizures, prevention of seizure recurrence and rapid drug substitution].
    Sokić D; Janković SM
    Srp Arh Celok Lek; 1994; 122(3-4):78-81. PubMed ID: 17972815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged impairment of the plasma-protein binding of phenytoin in the rat after a single dose of sodium oleate.
    Colburn WA; Gibaldi M
    Drug Metab Dispos; 1978; 6(4):452-5. PubMed ID: 28926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenytoin cumulation profiles.
    Yuen GJ; Bell RD; Ludden TM
    Res Commun Chem Pathol Pharmacol; 1983 Dec; 42(3):355-68. PubMed ID: 6665297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein-bound and free plasma phenytoin during pregnancy.
    Lecomte M; Albengres E; Huraux-Rendu C; Tillement JP; Gautray JP
    Int J Biol Res Pregnancy; 1981; 2(2):95-8. PubMed ID: 7333696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life-threatening cardiotoxicity due to chronic oral phenytoin overdose.
    Su CM; Kung CT; Wang YC; Lu CH
    Neurol India; 2009; 57(2):200-2. PubMed ID: 19439856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative bioavailability of 2 oral solid phenytoin dosage forms.
    Naik D; Morton DJ
    Cent Afr J Med; 1989 Apr; 35(4):384-8. PubMed ID: 2605620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged use of phenytoin, carbamazepine or valproate monotherapy on plasma levels of folate and B(12): a comparison between epileptic patients with or without cardiovascular disorders.
    Otoom S; Bakhiet M; Khan A; Sequeira R
    Neuro Endocrinol Lett; 2006; 27(1-2):85-8. PubMed ID: 16648782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Severe phenytoin intoxication in patients with hypoalbuminaemia].
    Kemper EM; van Kan HJ; Speelman P; de Gans K; Beijnen JH; Schellens JH
    Ned Tijdschr Geneeskd; 2007 Jan; 151(2):138-41. PubMed ID: 17315493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronotherapeutic dose schedule of phenytoin and carbamazepine in epileptic patients.
    Yegnanarayan R; Mahesh SD; Sangle S
    Chronobiol Int; 2006; 23(5):1035-46. PubMed ID: 17050216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transsynovial kinetics of lonazolac and its hydroxy metabolite in synovitis patients.
    Deneke J; Luckow V; Guserle R; Pässler HH
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):418-24. PubMed ID: 9726694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-regulation of phenytoin and tolbutamide metabolism in humans.
    Tassaneeyakul W; Veronese ME; Birkett DJ; Doecke CJ; McManus ME; Sansom LN; Miners JO
    Br J Clin Pharmacol; 1992 Dec; 34(6):494-8. PubMed ID: 1493081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic drug monitoring and clinical outcomes in epileptic Egyptian patients: a gene polymorphism perspective study.
    Ebid AH; Ahmed MM; Mohammed SA
    Ther Drug Monit; 2007 Jun; 29(3):305-12. PubMed ID: 17529887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.